Our results suggest that the RGD motif of full-length TGFBI is necessary, but not sufficient, for ovarian cancer cell adhesion, thus indicating it may cooperate with flanking residues or other motifs, potentially present within the fourth Fasciclin I domain to mediate this process. The gene discussed is TGFBI; the disease is ovarian carcinoma.